In laboratory experiments, researchers have produced ear cartilage that remains form-stable in animal models. Only one element is missing to make the tissue as elastic as a natural ear.
Researchers at Tezpur University in Assam, India, working with scientists at the University of Illinois Urbana-Champaign, have identified distinct chemical signatures in blood that could help detect gallbladder cancer earlier. This is important in cancer patients with and without gallstones, two groups that often require different diagnostic approaches.
Recent technological advances have opened new possibilities for the development of advanced medical devices, including tiny robots that can safely move inside the human body. Some of these systems could help to simplify complex medical procedures, including delicate surgeries and the targeted delivery of drugs to specific sites.
Recor Medical is gaining reimbursement in Japan’s healthcare system for its Paradise renal denervation for treating hypertension, enabling it to better compete with Medtronic’s rival Symplicity Spyral system.
Olympus announced today that it received FDA clearance for pediatric use for two of the single-use bronchoscopes it distributes in the U.S.
BOSTON, Feb. 23, 2026 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the NexSys PCS® Plasma Collection System with Persona® PLUS technology. Persona PLUS represents the next generation of Haemonetics’ proprietary and patented Persona technology that tailors plasma collections to each donor for improved average plasma volume per donation.
ATLANTA, Feb. 23, 2026 /PRNewswire/ — MiRus® today announced FDA 510(k) clearance and commercial launch of the IO™ Expandable Wedge Osteotomy System, an innovative solution designed to bring intraoperative precision and adjustability to foot and ankle osteotomy procedures.
One way cancer specialists detect the disease is by examining cells and bodily fluids under a microscope, a time-consuming and labor-intensive process called cytology. It involves visually inspecting tens of thousands to one million cells per slide for subtle 3D morphological changes that might signal the onset of cancer. But AI offers an approach that is potentially faster and more accurate.
Researchers from several partner institutions of the German Center for Diabetes Research (DZD) have collaborated with international colleagues to develop a new approach for visualizing subtle tissue changes in the pancreas in type 2 diabetes. The results provide new insights into the development of type 2 diabetes. The study has now been published in Nature Communications.
Using machine learning, an electronic nose can “smell” early signs of ovarian cancer in the blood. The method is precise and, according to the LiU researchers behind the study, it could eventually be used to find many different cancers. The study is published in Advanced Intelligent Systems.